Pharmacogenomics Corner

Back to articles

Pharmacogenomic testing: Physicians ready but need to know more

KEY POINT

Physician education is the key to greater implementation of pharmacogenomic testing in daily practice, according to results of a recently published survey. While most physician respondents agreed that a patient’s genetic profile may influence drug therapy, only a small number of physicians believed they were well informed about genetic testing. A lack of education about pharmacogenomic (PGx) test availability, clinical value, and result interpretation contributed to low adoption of the technology as a means of informing clinical decision making.

SOURCES

Stanek EJ et al. Adoption of pharmacogenomic testing by U.S. physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91:450–8. 

Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286:487–91.

Lunshof JE, Gurwitz D. Pharmacogenomic testing: knowing more, doing better. Clin Pharmacol Ther. 2012;91:387–9. 

Haga SB et al. Survey of US public attitudes toward pharmacogenetic testing. Pharmacogenomics J. 2011: doi:10.1038/tpj.2011.1. 

McCullough KB et al. Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ. 2011;75:51. 

Roederer MW et al. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Per Med. 2012;9:19–27.